Skip to content

GHRS - GH Research PLC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchG

GH Research PLC

GHRS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

G

GHRSGH Research PLC

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $31.44
52-wk low: $11.83
Prev close: $22.15
Mkt cap: $2.05B
Beta: 1.29
P/B: 5.7x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$196.9M

MI
Millennium
Israel Englander · Q2 2026 13F
$8.7M
position
VE
Verition
Nicholas Maounis · Q4 2025 13F

Earnings

Reported Aug 6, 2026

Earnings came in 25.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $2.0B

Valuation

P/B5.68

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: GHRS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $2.05B
Beta: 1.29

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-18.8%

$8.6M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$2.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for GHRS

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.23+25.8%

-$0.31 expected

Next report

What the street expects next

-18.8%

ROA-13.0%

Growth

Beta1.29